SP1 and diabetes mellitus: In summary, our work delineates how the AMPK-regulated SP1 pathway leads to diabetes-responsive transcription of dynein genes, provides a better understanding of the initial steps of dynein-driven pathogenesis of DN, and identifies a new molecular target for remodeling dynein-mediated pathology in vivo.